TRPC5 and breast carcinoma: In order to investigate the clinical potential of TRPC5 in the induction of autophagy in breast cancer, we analyzed breast cancer tissue from 31 paired patients with or without anthracycline-taxane-based chemotherapy (Supplementary Table S1).